A new international study led by University of Sydney has found that medication use increases in newly diagnosed dementia patients, particularly unnecessary or inappropriate medications.
Apr 19, 2018
0
40
A new class of cholesterol-lowering drug has been found to help patients cut their risk of cardiovascular disease, stroke and heart attack.
Mar 17, 2017
1
71
Giving patients with chronic obstructive pulmonary disease (COPD) newly available oral phosphodiesterase 4 (PDE4) inhibitors, roflumilast or cilomilast, improves lung function and reduces the likelihood of a flareup, but ...
May 11, 2011
0
0
A world-first trial at UCL and UCLH has found a new genetic therapy for Alzheimer's disease that is able to safely and successfully lower levels of the harmful tau protein known to cause the disease.
Apr 25, 2023
0
76
A new study published in JAMA Pediatrics shows that since 2003, the use of alternative medicines, such as herbal products and nutraceuticals, among children has doubled. The University of Illinois at Chicago researchers who ...
Jun 18, 2018
0
10
(HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.
Apr 29, 2013
0
0
Over the past two decades, numerous complex cancer therapies called antibody drug conjugates (ADCs) have been tested in clinical trials and approved for use in patients. Investigators recently performed a comprehensive analysis ...
Nov 21, 2022
0
4
Results from CREDO-Kyoto PCI/CABG Registry Cohort-2 show that percutaneous coronary intervention (PCI) was associated with significantly higher risk for serious adverse events in patients with triple vessel disease than coronary ...
Aug 29, 2011
0
0
Loyola University Hospital spine surgeon Dr. Alexander Ghanayem is co-author of a landmark editorial challenging the integrity of published industry-sponsored research involving a bone-growth product.
Jun 28, 2011
0
0
(HealthDay)—In patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), B-cell depletion using several infusions of rituximab over 12 months is not associated with clinical improvement, according to a ...
Apr 6, 2019
0
0
